🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Allaire Manon presentig the lack of 100% accuracy of Baveno criteria to predict portal hyp or varices in patients with HCC. Chaired by P Nahon at #EASLCongress 2023

Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote #liverregeneration 🔓#OpenAccess at👉bit.ly/3KnAuC1 Allaire Manon #LiverTwitter

The 17th edition of the ILCA Annual Conference has been a great success, thanks to the active participation of our attendees and speakers coming from across the world. Thanks to all of you! 🫶 Watch the #ILCA23 Aftermovie and discover the highlights of the conference that

🤝 Join hands with us to spread knowledge about #livercancer and save lives. Together, we can make a significant impact! #EUCancerPlan #LiverCancerAwarenessMonth #EuropeanLiverScreeningWeek #Alcohol #Hepatitis #obesity #FattyLiver #MASH EU One Health 🩺👥 EU One Health WHO/Europe

🎗️💚 October is Liver Cancer Awareness Month! Hear from Bruno Sangro and Manon Allaire, ILCA Advocacy ambassadors, how important it is for ILCA to put patients at the core of our activities. Let's unite to raise awareness, support those affected, prioritize early detection and

🤩 Glad to meet very good friends at #ESMO2023 and profit to plan 👩🏻‍💻our ILCA #HCC patient advocacy project for systemic therapies leaded by Allaire Manon under the guidance of Prof Sangro 🙌🏻 BCLC GROUP Hospital Clínic ESMO - Eur. Oncology #livertwitter

Make sure to join the online event "Together, Ensuring Deserved Care for Every Liver Cancer Patient" to hear Lorenza Rimassa and Manon Allaire discussing with many other inspiring speakers the importance of delivering appropriate care to all #livercancer patients. Stay tuned to

Glad and honored to be part of Digestive Cancers Europe event “Together, Ensuring Deserved Care for Every Patient with #LiverCancer” Allaire Manon ILCA AMMF Humanitas University Humanitas Milano #LiverCancerAwarenessMonth #HCC #CCA

#LiverCancerAwarenessMonth | Diagnostic en 7 jours du #cancerdufoie : un diagnostic et une prise en charge thérapeutique pluridisciplinaire au Centre de diagnostic rapide de la Pitié-Salpêtrière. ➡️ Infos : 01 42 17 56 47 Assistance Publique – Hôpitaux de Paris (AP-HP) Faculté de Santé de Sorbonne Université Allaire Manon #cancerfoie

#Frailty evaluation is complex but deserves our attention in the management of our patients #HCC and #cirrhosis. The main role is for the nurses here nllarch gemma iserte Annalisa Berzigotti Allaire Manon BCLC GROUP European Liver Patients' Association ILCA EASL Education

Was happy to explain the BCLC GROUP philosophy and human touch to blend care and research. Attendees said that it was inspirational “mentoring”. Hence, success!! Thanks to Allaire Manon Jean-Charles Nault for their friendship Hospital Clínic IDIBAPS

Bravo Manon pour le financement de ce projet de recherche au sein de notre équipe. Nous sommes honorés de développer ces projets translationnels

Interesting academic lecture given by the one and only Allaire Manon in our hepatology ward about the maze of HCC and portal hypertension! Few conclusions (thread)

A meet the experts with several experts promotes a fantastic interactive session #EASLCongress EASL Education EASLnews Allaire Manon Annalisa Berzigotti Maria Reig Sherrie Bhoori Giuseppe Cabibbo Marco Sanduzzi Zamparelli

Great discussions at EASLnews #EASLConference on the very difficult issues that arise when considering HCC therapy for patients with Child Pugh B cirrhosis

Intense and active #HCC day at #EASL2024 Sherrie Bhoori Matthias Pinter Giuseppe Cabibbo Allaire Manon Guadalupe GarciaTsao Jean-Charles Nault Annalisa Berzigotti BCLC GROUP Lorenza Rimassa Eric Vibert et al 👌 science 🙌 provocative discussion 💪🙌 networking & frienship

ITT outcomes of pts with HCC receiving immunotherapy before liver transplant Journal of Hepatology doi.org/10.1016/j.jhep… 🔎🇺🇸VITALITY study 👉86 pts 👉75.6% downstaged 👉36% LTx 👉3-year ITT OS 71.1% 👉 7 rejections, 1 graft lost 🧐More evidence to support ICI before LTx ESMO - Eur. Oncology

🗓️ 30 Sep ⏰ 17 CEST Transplant International EL HAJJI Sofia B Moeckli Christian Toso Chiara Becchetti Umberto Cillo Allaire Manon 👉 Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of #LiverTransplant Candidates With Hepatocellular Carcinoma

🚨 Reminder! 🗓️ 30 Sep 🕔 17:00 CEST Transplant International Journal Club 🗣️ EL HAJJI Sofia B Moeckli Christian Toso Umberto Cillo Allaire Manon Chiara Becchetti Don’t miss it! #LiverTransplant #PoweredByESOT 🏓 Maria Irene Bellini MD, PhD, FEBS, FACS Louise Benning go.esot.org/ti_jc_30sep2024